share_log

Doximity analyst ratings

Doximity analyst ratings

Doximity分析师评级
Benzinga Analyst Ratings ·  2022/05/19 18:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
05/19/2022 45.07% Piper Sandler $81 → $44 Maintains Overweight
05/18/2022 71.45% Guggenheim $70 → $52 Maintains Buy
05/18/2022 51.67% Jefferies $78 → $46 Maintains Buy
05/18/2022 31.88% Raymond James $60 → $40 Maintains Outperform
05/18/2022 15.4% Morgan Stanley $55 → $35 Maintains Equal-Weight
05/18/2022 48.37% Baird $68 → $45 Maintains Outperform
05/18/2022 48.37% Needham $70 → $45 Maintains Buy
05/18/2022 120.9% SVB Leerink $72 → $67 Maintains Outperform
04/07/2022 130.79% Guggenheim → $70 Initiates Coverage On → Buy
04/04/2022 81.34% B of A Securities → $55 Initiates Coverage On → Neutral
03/23/2022 81.34% Morgan Stanley $62 → $55 Maintains Equal-Weight
02/11/2022 143.98% Goldman Sachs → $74 Initiates Coverage On → Buy
02/09/2022 97.82% Raymond James $80 → $60 Maintains Outperform
02/09/2022 130.79% Needham $90 → $70 Maintains Buy
12/17/2021 91.23% Morgan Stanley $72 → $58 Maintains Equal-Weight
12/14/2021 97.82% JP Morgan $70 → $60 Downgrades Neutral → Underweight
12/02/2021 157.17% Jefferies → $78 Initiates Coverage On → Buy
11/17/2021 176.95% Baird → $84 Initiates Coverage On → Outperform
11/10/2021 163.77% Raymond James $62 → $80 Maintains Outperform
11/10/2021 196.74% Needham $62 → $90 Maintains Buy
11/10/2021 137.39% SVB Leerink $65 → $72 Maintains Outperform
08/31/2021 134.09% Morgan Stanley $52 → $71 Maintains Equal-Weight
08/26/2021 130.79% JP Morgan → $70 Downgrades Overweight → Neutral
08/11/2021 104.42% Raymond James $60 → $62 Maintains Outperform
07/19/2021 71.45% Morgan Stanley → $52 Initiates Coverage On → Equal-Weight
07/19/2021 97.82% Raymond James → $60 Initiates Coverage On → Outperform
07/19/2021 104.42% Needham → $62 Initiates Coverage On → Buy
07/19/2021 — William Blair Initiates Coverage On → Outperform
07/19/2021 111.01% Canaccord Genuity → $64 Initiates Coverage On → Buy
07/19/2021 114.31% SVB Leerink → $65 Initiates Coverage On → Outperform
07/19/2021 124.2% Piper Sandler → $68 Initiates Coverage On → Overweight
07/19/2021 18.69% Goldman Sachs → $36 Initiates Coverage On → Neutral
07/19/2021 97.82% JP Morgan → $60 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
05/19/2022 45.07% 派珀·桑德勒 $81 → $44 维护 超重
05/18/2022 71.45% 古根海姆 $70 → $52 维护 买
05/18/2022 51.67% 杰富瑞 $78 → $46 维护 买
05/18/2022 31.88% 雷蒙德·詹姆斯 $60 → $40 维护 跑赢大盘
05/18/2022 15.4% 摩根士丹利 $55 → $35 维护 等重
05/18/2022 48.37% 贝尔德 $68 → $45 维护 跑赢大盘
05/18/2022 48.37% 李约瑟 $70 → $45 维护 买
05/18/2022 120.9% SVB Leerink $72 → $67 维护 跑赢大盘
04/07/2022 130.79% 古根海姆 → $70 开始承保 →购买
04/04/2022 81.34% B of A证券 → $55 开始承保 →中性
03/23/2022 81.34% 摩根士丹利 $62 → $55 维护 等重
02/11/2022 143.98% 高盛 → $74 开始承保 →购买
02/09/2022 97.82% 雷蒙德·詹姆斯 $80 → $60 维护 跑赢大盘
02/09/2022 130.79% 李约瑟 $90 → $70 维护 买
12/17/2021 91.23% 摩根士丹利 $72 → $58 维护 等重
12/14/2021 97.82% 摩根大通 $70 → $60 评级下调 中性→减持
12/02/2021 157.17% 杰富瑞 → $78 开始承保 →购买
11/17/2021 176.95% 贝尔德 → $84 开始承保 →跑赢大盘
11/10/2021 163.77% 雷蒙德·詹姆斯 $62 → $80 维护 跑赢大盘
11/10/2021 196.74% 李约瑟 $62 → $90 维护 买
11/10/2021 137.39% SVB Leerink $65 → $72 维护 跑赢大盘
08/31/2021 134.09% 摩根士丹利 $52 → $71 维护 等重
08/26/2021 130.79% 摩根大通 → $70 评级下调 超重→中性
08/11/2021 104.42% 雷蒙德·詹姆斯 $60 → $62 维护 跑赢大盘
07/19/2021 71.45% 摩根士丹利 → $52 开始承保 →等重
07/19/2021 97.82% 雷蒙德·詹姆斯 → $60 开始承保 →跑赢大盘
07/19/2021 104.42% 李约瑟 → $62 开始承保 →购买
07/19/2021 — 威廉·布莱尔 开始承保 →跑赢大盘
07/19/2021 111.01% 卡纳科特·格纳奇 → $64 开始承保 →购买
07/19/2021 114.31% SVB Leerink → $65 开始承保 →跑赢大盘
07/19/2021 124.2% 派珀·桑德勒 → $68 开始承保 →超重
07/19/2021 18.69% 高盛 → $36 开始承保 →中性
07/19/2021 97.82% 摩根大通 → $60 开始承保 →超重

Doximity Questions & Answers

多氧性问题与解答

What is the target price for Doximity (DOCS)?
Doximity(DOCS)的目标价是多少？

The latest price target for Doximity (NYSE: DOCS) was reported by Guggenheim on May 18, 2022. The analyst firm set a price target for $52.00 expecting DOCS to rise to within 12 months (a possible 71.45% upside). 32 analyst firms have reported ratings in the last year.

古根海姆于2022年5月18日报道了Doximity(纽约证券交易所代码：DOCS)的最新目标价。这家分析公司将目标价定为52.00美元，预计DOCS将在12个月内上涨至71.45%。去年有32家分析公司公布了评级。

What is the most recent analyst rating for Doximity (DOCS)?
Doximity(DOCS)的最新分析师评级是多少？

The latest analyst rating for Doximity (NYSE: DOCS) was provided by Guggenheim, and Doximity maintained their buy rating.

古根海姆对Doximity(纽约证券交易所代码：DOCS)的最新分析师评级为买入，Doximity维持买入评级。

When is the next analyst rating going to be posted or updated for Doximity (DOCS)?
Doximity(DOCS)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on May 18, 2022 so you should expect the next rating to be made available sometime around May 18, 2023.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Doximity的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Doximity的上一次评级是在2022年5月18日提交的，所以你应该预计下一次评级将在2023年5月18日左右的某个时候公布。

Is the Analyst Rating Doximity (DOCS) correct?
分析师评级Doximity(DOCS)正确吗？

While ratings are subjective and will change, the latest Doximity (DOCS) rating was a maintained with a price target of $70.00 to $52.00. The current price Doximity (DOCS) is trading at is $30.33, which is out of the analyst's predicted range.

虽然评级是主观的，会发生变化，但最新的Doximity(DOCS)评级保持不变，目标价在70.00美元到52.00美元之间。Doximity(DOCS)目前的交易价格为30.33美元，超出了分析师的预测区间。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发